VanEck Bionic Engineering UCITS ETF
- Profit from a fast evolution via Bionic ETF
- High-tech healthcare that positively impacts people and planet
- Growing demand from a fast-ageing global population
Bionics is biology-inspired engineering. It applies concepts and systems found in nature to the design of advanced medical devices. Companies in this area make devices including artificial heart valves, insulin pumps, pacemakers and joint replacements. Technological advances are improving the capabilities of these devices and promise to make far more possible. Think of brain chips that cure deafness, bioprinting that regenerates joints or exoskeletons that restore mobility.
Risks of Bionic ETF: You may lose money up to the total loss of your investment due to the Main Risk Factors, such as Industry or Sector Concentration Risk and Liquidity Risks described below in the KID and the sales prospectus. Evolving of the market is not guaranteed.
Experts anticipate there are four stages to the biomachine interface evolution.1 Below are some examples:
1 Source: McKinsey Global Institute.
Bionics is a fast-expanding medical field set to fulfill a substantial need. Bionic ETF by VanEck offers one of the few ways to invest in a diversified portfolio of companies.
Today the companies underlying the Bionic ETF specialize in a range of fields, from heart valves to medical implants and diabetes monitoring devices. They include Edwards Lifesciences, a leader in artificial heart valves; Medtronic, which makes insulin pumps and pacemakers; and Stryker Corp, known for its joint replacements. As the new interfaces between man and machine evolve, so will Bionic ETF’s holdings.